Reletrans (buprenorphine): Reviews and patient testimonials
Medication indications
Reletrans 10 microgram/hour transdermal patch
Treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. Reletrans is not suitable for the treatment of acute pain.Reletrans is indicated in adults.Reletrans 15 microgram/hour transdermal patch
Treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. Reletrans is not suitable for the treatment of acute pain.Reletrans is indicated in adults.Reletrans 20 microgram/hour transdermal patch
Treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. Reletrans is not suitable for the treatment of acute pain.Reletrans is indicated in adults.Reletrans 5 microgram/hour transdermal patch
Treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. Reletrans is not suitable for the treatment of acute pain.Reletrans is indicated in adults.Route of administration: opinion.traitement.transdermal
Molecule: buprenorphine
Patients' opinions on Reletrans
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.